Geoffrey Lynn
InvestorEntrepreneur in Residence at Blackbird Bioventures
Find your path to Geoffrey
Sign up to find every way you can get introduced to Geoffrey
- Your email: the people you already email who know Geoffrey
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Geoffrey
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Entrepreneur in Residence and founding CEO of Aletira Therapeutics. Founded and led Avidea Technologies through its acquisition by Vaccitech (now Barinthus). Holds an MD from Johns Hopkins and a PhD in Biomedical Engineering from Oxford.
Colleagues at Blackbird Bioventures
Adair Newhall
Advisory Board; Steering Board; Partner, Stepstone Group at Blackbird Bioventures
Amir Zamani
Advisory Board; Partner, Bain Capital at Blackbird Bioventures
Anthony Accorsi
Venture Partner at Blackbird Bioventures
Ashlei Chang
Office Manager at Blackbird Bioventures
Avi Khanna
Senior Director, Molecular Discovery at Blackbird Bioventures
Bridget Duvall
Director, Lab Operations at Blackbird Bioventures
Chau Q. Khuong
Advisory Board; Founder & Chief Investment Officer, CJNV BioVentures at Blackbird Bioventures
Chris Jewell
Entrepreneur in Residence at Blackbird Bioventures
Frequently asked questions
- Who is Geoffrey Lynn?
- Entrepreneur in Residence and founding CEO of Aletira Therapeutics. Founded and led Avidea Technologies through its acquisition by Vaccitech (now Barinthus). Holds an MD from Johns Hopkins and a PhD in Biomedical Engineering from Oxford.
- Where does Geoffrey Lynn work?
- Geoffrey Lynn is Entrepreneur in Residence at Blackbird Bioventures.